BRCA-Mutated

3 clinical trials · Condition

Record	Firm	Date
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy (NCT01874353)	AstraZeneca	2013-09-03
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors (NCT01853306)	AbbVie	2013-03-18

Every clearance here is in the API, with alerts when new ones post.